The mast cell and allergic diseases: Role in pathogenesis and implications for therapy

Clinical and Experimental Allergy

Volumn 38, Issue 6, 2008, Pages 1063-1064

  Edwards, A ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN E; NEDOCROMIL SODIUM; PLACEBO;

ALLERGY; ASTHMA; HISTAMINE RELEASE; HUMAN; LETTER; MAST CELL; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; TACHYPHYLAXIS; TONSIL;

ASTHMA; CELL DEGRANULATION; CHILD; CHILD, PRESCHOOL; CHROMONES; HUMANS; MAST CELLS; MASTOCYTOSIS; TACHYPHYLAXIS;

EID: 44249084452     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.03000.x     Document Type: Letter

References (16)

1. Brown JM, Wilson TM, Metcalfe DD. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy 2008 38 : 4 18.
2. Sheard P, Blair AM. Disodium cromoglycate. Activity in three in vitro models of the immediate hypersensitivity reaction in lung. Int Arch Allergy Appl Immunol 1970 38 : 217 24.
3. Leung KB, Flint KC, Brostoff J et al. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. Thorax 1988 43 : 756 61.
4. Flint KC, Leung KB, Pearce FL, Hudspith BN, Brostoff J, Johnson NM. Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate. Clin Sci (Lond) 1985 68 : 427 32.
5. Walsh LJ. Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumour necrosis factor-alpha. Immunol Cell Biol 1995 73 : 226 33.
6. Okayama Y, Benyon RC, Rees PH, Lowman MA, Hillier K, Church MK. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy 1992 22 : 401 9.
7. Bissonnette EY, Enciso JA, Befus AD. Inhibition of tumour necrosis factor-alpha (TNF-alpha) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium. Clin Exp Immunol 1995 102 : 78 84.
8. Edwards A. Long-term study of disodium cromoglycate in treatment of severe extrinsic or intrinsic bronchial asthma in adults. Brompton Hospital-Medical Research Council collaborative trial. Br Med J 1972 4 : 383 8.
9. Edwards A. Sodium cromoglycate in chronic asthma. Br Med J 1976 1 : 361 4.
10. Silverman M, Connolly NM, Balfour-Lynn L, Godfrey S. Long-term trial of disodium cromoglycate and isoprenaline in children with asthma. Br Med J 1972 3 : 378 81.
11. Godfrey S, Balfour-Lynn L, Konig P. The place of cromolyn sodium in the long-term management of childhood asthma based on a 3- to 5-year follow-up. J Pediatr 1975 87 : 465 73.
12. Smith JM. Prolonged use of disodium cromoglycate in children and young persons - ten years experience. Schweiz Med Wochenschr 1980 110 : 183 4.
13. Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 1979 301 : 465 9.
14. Horan RF, Sheffer AL, Austen KF. Cromolyn sodium in the management of systemic mastocytosis. J Allergy Clin Immunol 1990 85 : 852 5.
15. Businco L, Cantani A, Businco E, Pepys J. Systemic mastocytosis in a 5-year-old child: successful treatment with disodium cromoglycate. Clin Allergy 1984 14 : 147 52.
16. Stevens MT, Edwards AM, Howell JB. Sodium cromoglicate: an ineffective drug or meta-analysis misused? Pharm Stat 2007 6 : 123 37.